Akademisyen
BİRSEN YÜCEL
PROFESÖR
SİVAS CUMHURİYET ÜNİVERSİTESİ TIP FAKÜLTESİ DAHİLİ TIP BİLİMLERİ BÖLÜMÜ
- Ana Dal Sağlık Bilimleri Temel Alanı
- Yan Dal Radyasyon Onkolojisi
Kayıtlı çıktılara kısa bakış — ayrıntılar aşağıda.
- Makale 140
- Proje 0
- Kitap 0
- Bildiri 0
- Patent 0
- Sanatsal 0
Scopus (SJR)
Q1
8
Q2
30
Q3
19
Q4
39
WoS (JCR)
Q1
8
Q2
17
Q3
18
Q4
35
TR Index
56
makale
Alan+yıl+tür normalize OpenAlex yüzdelik — Clarivate ESI / SciVal değildir.
Üst %1 makale
0
Üst %10 makale
3
Ort. yüzdelik
50.1%
Üst %1 payı
0.0%
Üst %10 payı
3.1%
Makaleler
YÖKSİS ve OpenAlex kaynak ayrımıyla makaleler; quartile ve TR Index ile daraltabilirsiniz.
Makale listesi
- 2026 Neutrophil Percentage-to-Albumin Ratio as a Prognostic and Predictive Biomarker in Non-Metastatic Breast Cancer Treated with Neoadjuvant Chemotherapy: Findings from a Retrospective Cohort YÖKSİS SJR Q2 JCR Q1 OpenAlex 25.1%
- 2025 Prognostic Importance of Panimmune-Inflammation Value and PILE Scores in Non-Metastatic Luminal A Breast Cancer YÖKSİS SJR Q2 JCR Q2 OpenAlex 71.9%
- 2025 Comparison of Invasive Ductolobular Carcinoma and Lobular Carcinoma: An Observational Study YÖKSİS SJR Q2 JCR Q1 OpenAlex 3.6%
- 2025 The Importance of Pan‐Immune‐Inflammation Value Score in Locally Advanced Rectal Cancer YÖKSİS SJR Q2 JCR Q2 OpenAlex 82.7%
- 2025 The cluster of differentiation 47 expression in rectal cancer and efficacy of neoadjuvant therapies YÖKSİS TR Index OpenAlex 16.3%
- 2025 Is high-density lipoprotein cholesterol a prognostic marker in epithelial ovarian cancer? YÖKSİS SJR Q3 JCR Q2 OpenAlex 64.1%
- 2025 Failure patterns and the influence of the TNM staging systems on prognosis in limited disease small cell lung Cancer (SCLC): the Turkish Oncology Group (TOG) study YÖKSİS SJR Q2 JCR Q3 OpenAlex 29.9%
- 2024 Effects of hormone receptor status on patient clinic and survival in HER2 positive breast cancer YÖKSİS SJR Q2 JCR Q3 OpenAlex 44.2%
- 2024 Special types of breast cancer: Clinical, Histological Features and Survival Outcomes YÖKSİS OpenAlex 19.3%
- 2024 Küçük Hücreli Dışı Akciğer Kanseri Olgularında Torasik Radyoterapinin Yaşam Kalitesine Etkisinin Değerlendirilmesi YÖKSİS OpenAlex 19.2%
- 2024 Effects of weight intervention-induced changes in pathological fat mass of patients with extreme obesity and anorexia nervosa on adipokines and visceral adipocyte functions: a prospective, comparative, observational study YÖKSİS SJR Q2 JCR Q2 OpenAlex 59.1%
- 2024 Survival and prognostic factors in reirradiation for recurrent/progressive malignant gliomas: turkish society of radiation oncology neuro-oncology group, trod 007-006 study YÖKSİS TR Index SJR Q3 JCR Q4 OpenAlex 52.2%
- 2024 Who would be the winner? A prognostic nomogram for predicting the benefit of postoperative radiotherapy ± chemotherapy in patients with locally advanced gastric cancer: TROD-02-01 study YÖKSİS SJR Q2 JCR Q1 OpenAlex 52.5%
- 2024 İnvaziv lobüler meme karsinomunun klinik özellikleri ve sağkalim sonuçları YÖKSİS TR Index SJR Q4 JCR Q4 OpenAlex 65.1%
- 2023 “Evaluation of quality of life in patients with gastric adenocarcinoma receiving chemoradiotherapy: a cross-sectional study” YÖKSİS SJR Q1 JCR Q1 OpenAlex 73.4%
- 2023 Prognostic value of the systemic immune-inflammation index, systemic inflammation response index, and prognostic nutritional index in head and neck cancer YÖKSİS SJR Q1 JCR Q2 OpenAlex üst %10 OpenAlex 96.1%
- 2022 Factors Affecting Permanent Sensorineural Hearing Loss and Bone Conduction in Patients After Receiving Radiotherapy to the Head and Neck Region. YÖKSİS TR Index JCR Q4 OpenAlex 14.7%
- 2022 The Relationship between the SUVmax Value Obtained in Ga-68 PSMA PET/CT and Lactate Dehydrogenase and Alkaline Phosphatase in Prostate Cancer. YÖKSİS SJR Q4 JCR Q4
- 2021 Prognostic value of systemic ımmune ınflammation ındex in patients with laryngeal cancer YÖKSİS SJR Q1 JCR Q2 OpenAlex 86.9%
- 2020 Risk factors of radiation pneumonitis in patients with NSCLC treated with concomitant chemoradiotherapy––Are we underestimating diabetes?––Turkish oncology group (TOG)/Lung cancer study group YÖKSİS SJR Q2 JCR Q3 OpenAlex 82.4%